Patents Assigned to SKYHAWK THERAPEUTICS, INC.
  • Methods and compositions for modulating splicing
    Patent number: 11964971
    Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, pharmaceutical compositions comprising the same, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
    Type: Grant
    Filed: July 29, 2021
    Date of Patent: April 23, 2024
    Assignee: SKYHAWK THERAPEUTICS, INC.
    Inventors: Michael Luzzio, Brian Lucas, Tiansheng Wang, Jun Feng
  • Methods and compositions for modulating splicing
    Patent number: 11845744
    Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, pharmaceutical compositions comprising the same, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: December 19, 2023
    Assignee: Skyhawk Therapeutics, Inc.
    Inventors: Michael Luzzio, Brian Lucas, Daniel Brian Horne, Tiansheng Wang
  • COMPOSITIONS AND METHODS FOR CORRECTION OF ABERRANT SPLICING
    Publication number: 20230227474
    Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
    Type: Application
    Filed: March 13, 2020
    Publication date: July 20, 2023
    Applicant: SKYHAWK THERAPEUTICS, INC.
    Inventors: Michael Luzzio, Brian Lucas
  • Methods and compositions for modulating splicing
    Patent number: 11603531
    Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: March 14, 2023
    Assignee: SKYHAWK THERAPEUTICS, INC.
    Inventors: Michael Luzzio, Kathleen McCarthy, William Haney
  • Compounds for the treatment of cancer
    Patent number: 11530207
    Abstract: Described herein are splice modifying compounds affecting splicing of mRNA, such as pre-mRNA, expressed from the FOXM1 gene, compositions comprising thereof, and methods using the same.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: December 20, 2022
    Assignee: SKYHAWK THERAPEUTICS, INC.
    Inventors: Michael Luzzio, Kathleen McCarthy
  • Methods and compositions for modulating splicing
    Patent number: 11434489
    Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: September 6, 2022
    Assignee: Skyhawk Therapeutics, Inc.
    Inventors: Michael Luzzio, Kathleen McCarthy, William Haney
  • Methods and compositions for modulating splicing
    Patent number: 11326165
    Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: May 10, 2022
    Assignee: SKYHAWK THERAPEUTICS, INC.
    Inventors: Michael Luzzio, Kathleen McCarthy, William Haney
  • Methods and compositions for modulating splicing
    Patent number: 11162101
    Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: November 2, 2021
    Assignee: SKYHAWK THERAPEUTICS, INC.
    Inventors: Michael Luzzio, Kathleen McCarthy, William Haney
  • Methods for modulating splicing
    Patent number: 11129829
    Abstract: Described herein are methods of use of small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of treating diseases and conditions associated with gene expression or activity of proteins encoded by genes.
    Type: Grant
    Filed: March 9, 2020
    Date of Patent: September 28, 2021
    Assignee: SKYHAWK THERAPEUTICS, INC.
    Inventors: Michael Luzzio, Kathleen McCarthy, Botao Liu
  • Methods and compositions for modulating splicing
    Patent number: 11091475
    Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: August 17, 2021
    Assignee: SKYHAWK THERAPEUTICS, INC.
    Inventors: Michael Luzzio, Kathleen McCarthy, William Haney
  • Methods and compositions for modulating splicing
    Patent number: 11021708
    Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: June 1, 2021
    Assignee: SKYHAWK THERAPEUTICS, INC.
    Inventors: Michael Luzzio, Kathleen McCarthy, William Haney
  • Methods and compositions for modulating splicing
    Patent number: 11008572
    Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: May 18, 2021
    Assignee: SKYHAWK THERAPEUTICS, INC.
    Inventors: Michael Luzzio, Kathleen McCarthy, William Haney